Hi Evaluate... the company has indicated there is a publication the investigators are signing their name to. So whatever the information is in that publication cannot be discussed publicly until after it is released. It would be "embargoed".
You'll likely remember that term being used in the Spring of 2014 leading into ASCO, where there was a poster to be featured and so Linda could not tell us any data on how the Direct patients were doing until after the embargo lifted. Of course then MD Anderson's Dr. Buzdar became very offended at the idea of giving patients any hope; and he made sure to tell Adam about that. Well that's because he'd worked primarily with chemo and there is no hope to be found with that treatment. So to his way of thinking, it's much better to leave a patient in despair. I guess there are no glimmers of hope to be found at MD Anderson.
Still, that is what I meant by an embargo.
Market Data 
Markets 
AI
